ArticleAnnals of surgical oncology2025

Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients.

Julien Péron et al.PubMed ↗Publisher ↗

No numbers read from the abstract.